Alfieri Cardiology — Newark, Delaware

Alfieri Cardiology is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Alfieri Cardiology has participated in 12 clinical trials with 1 currently active.

Therapeutic areas: Coronary Artery Disease, Venous Thrombosis, Coronary Artery Disease (CAD).

Sponsors: Point Biomedical, Bristol-Myers Squibb, Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alfieri Cardiology?

Alfieri Cardiology has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alfieri Cardiology conducted?

Alfieri Cardiology has 12 clinical trials on record, with 1 currently active. Their work covers Coronary Artery Disease, Venous Thrombosis, Coronary Artery Disease (CAD).

Is Alfieri Cardiology accredited by Crixeo Health?

Yes — Alfieri Cardiology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Alfieri Cardiology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.